Loading…
Anixa Biosciences, Inc. is projected to rise to $4.30 by 2027, a +26% move from its current price of $3.42. ANIX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $3.30 | $3.42 | $3.54 | 0.00% |
| Aug 5 | $3.25 | $3.42 | $3.59 | -0.01% |
| Aug 6 | $3.22 | $3.42 | $3.63 | -0.01% |
| Aug 7 | $3.19 | $3.42 | $3.67 | -0.01% |
| Aug 8 | $3.16 | $3.42 | $3.70 | -0.01% |
| Aug 9 | $3.14 | $3.42 | $3.73 | -0.02% |
| Aug 10 | $3.12 | $3.42 | $3.75 | -0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.12 | $3.42 | $3.75 | -0.02% |
| Week 2 | $3.00 | $3.42 | $3.90 | -0.04% |
| Week 3 | $2.91 | $3.42 | $4.02 | -0.06% |
| Week 4 | $2.84 | $3.42 | $4.12 | -0.08% |
| Week 5 | $2.77 | $3.42 | $4.21 | -0.10% |
| Week 6 | $2.72 | $3.42 | $4.29 | -0.12% |
| Week 7 | $2.67 | $3.42 | $4.37 | -0.14% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Anixa Biosciences, Inc. is a biotechnology company in the Healthcare sector. It develops therapies and vaccines focused on oncology.
Anixa Biosciences, Inc. (ANIX) trades at $3.46 per share and has a market capitalization of $117.72M. Its current rank is 3943.
A major floor 37.6% below — a decisive break under it would weaken the trend.
The nearest floor, 23.4% below — buyers have tended to step in here.
The nearest ceiling, 9.6% above — a clean break opens room to run.
A major ceiling 28.5% above — clearing it would confirm fresh momentum.
Key ANIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.49 | Sell | $3.50 | Sell |
| MA 10 | $3.54 | Sell | $3.48 | Sell |
| MA 20 | $3.36 | Buy | $3.36 | Buy |
| MA 50 | $2.96 | Buy | $3.12 | Buy |
| MA 100 | $2.90 | Buy | $3.05 | Buy |
| MA 200 | $3.27 | Buy | $3.10 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.67 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 18.80 | Neutral |
| Williams %R (14) | -58.93 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -2.29 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 41.07 | Neutral |
| TRIX (15) | 0.92 | Buy |
| Awesome (5,34) | 0.36 | Buy |
| Ultimate (7,14,28) | 50.93 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 3.46 | Sell |
| ADX (14) | 21.04 | Buy |
| ATR (14) | 0.11 | Info |
The short-term technical picture is bullish.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.35 | $3.42 | $4.09 | 0% | Neutral | |
| $3.34 | $4.30 | $5.91 | +26% | Bullish | |
| $4.37 | $5.84 | $8.40 | +71% | Bullish | |
| $4.88 | $6.74 | $10.04 | +97% | Bullish | |
| $5.44 | $7.72 | $11.86 | +126% | Bullish | |
| $5.40 | $7.86 | $12.40 | +130% | Bullish | |
| $5.69 | $8.47 | $13.67 | +148% | Bullish | |
| $6.31 | $9.61 | $15.85 | +181% | Bullish | |
| $6.94 | $10.81 | $18.16 | +216% | Bullish | |
| $8.68 | $13.79 | $23.58 | +303% | Bullish | |
| $10.87 | $19.00 | $34.98 | +456% | Bullish | |
| $20.62 | $42.74 | $87.45 | +11.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.35 | $3.42 | $4.04 | +0.00% |
| September 2026 | $2.76 | $3.30 | $4.06 | -3.60% |
| October 2026 | $2.83 | $3.41 | $4.26 | +3.46% |
| November 2026 | $2.79 | $3.38 | $4.26 | -1.04% |
| December 2026 | $2.63 | $3.21 | $4.09 | -4.95% |
Click any year to see its month-by-month ANIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ANIX is projected to trade between $2.35 and $4.09, averaging $3.42 — a potential gain of 0% from today's $3.42. A consolidation phase looks the most probable path here.
Anixa Biosciences, Inc.'s 2027 outlook centres on $4.30, within a $3.34 to $5.91 range. That is up +26% on the projected 2026 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2028, ANIX could reach as high as $8.40, with a base case around $5.84 and support toward $4.37 — roughly +71% from $3.42. Buyers look set to stay in control over this stretch.
Expect ANIX to range from $4.88 to $10.04 through 2029. The $6.74 average target implies a +97% move from current prices. That is up +15% on the projected 2028 average. Momentum favours further upside here.
The ANIX price prediction for 2030 points to an average of $7.72 (low $5.44, high $11.86) — a potential gain of +126% on today's $3.42. Buyers look set to stay in control over this stretch.
In 2031, ANIX is projected to trade between $5.40 and $12.40, averaging $7.86 — a potential gain of +130% from today's $3.42. That is up +2% on the projected 2030 average. Momentum favours further upside here.
Anixa Biosciences, Inc.'s 2032 outlook centres on $8.47, within a $5.69 to $13.67 range. That is up +8% on the projected 2031 average. That marks a +148% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ANIX could reach as high as $15.85, with a base case around $9.61 and support toward $6.31 — roughly +181% from $3.42. Momentum favours further upside here.
Expect ANIX to range from $6.94 to $18.16 through 2034. The $10.81 average target implies a +216% move from current prices. That is up +12% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ANIX price prediction for 2035 points to an average of $13.79 (low $8.68, high $23.58) — a potential gain of +303% on today's $3.42. Momentum favours further upside here.
In 2040, ANIX is projected to trade between $10.87 and $34.98, averaging $19.00 — a potential gain of +456% from today's $3.42. That is up +38% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Anixa Biosciences, Inc.'s 2050 outlook centres on $42.74, within a $20.62 to $87.45 range. That is up +125% on the projected 2040 average. That marks a +11.5x change versus current levels. Momentum favours further upside here.
Investing $1,000 in ANIX today (≈ 292.397661 ANIX) could be worth
$12,497.57
+$11,497.57 (+1150%) by 2050 · US Dollar
Based on the average projected ANIX price of $42.74 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANIXwould be worth at today's price.
$1,000 invested in ANIX on Jul 31, 2025 (≈ 326.797392 ANIX) would be worth
$1,117.65
+$117.65 (+11.8%) today · 1.12× · US Dollar
Based on a ANIX entry price of $3.06 vs. today's $3.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.7 | $924.32 | -7.6% |
| 1 month ago | $3.14 | $1,089.17 | +8.9% |
| 3 months ago | $3.14 | $1,089.17 | +8.9% |
| 6 months ago | $2.94 | $1,163.27 | +16.3% |
| 1 year ago | $3.06 | $1,117.65 | +11.8% |
| All time (5.0y) ago | $4.15 | $824.1 | -17.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANIX forecast.
Our base-case forecast reaches $6.80 around 2030.
Implied market cap at $6.80: $231.36M
The year-by-year forecast shows a rising trajectory with multiple milestones. In 2026 the avg price is $3.46, and in 2027 the avg price is $4.28. The forecast continues to rise through 2028 (avg $5.79), 2029 (avg $6.60), and 2030 (avg $7.59) with an ROI of 119.3%.
In 2040 the avg price is $16.87 with an ROI of 387.7%, and in 2050 the avg price is $37.93 with an ROI of 996.4%. The sentiment for 2026 is NEUTRAL, and it is BULLISH for 2027 through 2050.
Tap a question to reveal the answer.
2030 avg $7.59, min $5.17, max $12.07; ROI 119.3%; sentiment BULLISH.
The forecast shows a bullish path with rising avg prices and ROI across years, but 2026 has ROI 0% and these are estimates, not guarantees.
2035 max $22.99; 2030 max $12.07; 2040 max $32.69; 2050 max $82.37, so a $20 target could be reached in 2035 according to the forecast.
Current price is $3.46 and market cap is $117.72M.
Sentiment is BULLISH; RSI14 is 60; SMA50 is $2.88; SMA200 is $3.29; 30-day range is $2.66-$4.51 with support at $2.47 and resistance at $3.75.
Anixa Biosciences, Inc. Community Discussion
0Share your Anixa Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.